Coia Dulsat

1 week ago | bioworld.com | Coia Dulsat

Home » EACR 2025: A look into next-generation strategies in cancer BioWorld briefs for June 18, 2025. BioWorld MedTech briefs for June 18, 2025. BioWorld Asia briefs for June 17, 2025 In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...

1 week ago | bioworld.com | Coia Dulsat

CancerEACR 2025: Immune rewiring in cancer orchestrates tumor microenvironmentAmong the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR) in Lisbon, it is worth highlighting two that respectively addressed the role of cytokines and lipid-sensing receptors as key modulators of the tumor microenvironment, a central theme in current cancer research. BioWorld Science Conferences Cancer

3 weeks ago | bioworld.com | Coia Dulsat

Researchers from the University of Arizona have unveiled that coordinated Y chromosome loss in both cancer cells and immune cells may explain the worse prognosis in people with this alteration. The loss of the Y chromosome (LOY) is one of the most frequent somatic mutations in men, particularly with advancing age. More specifically, LOY shows increasing prevalence in circulating blood cells, affecting around 2.5% of 40-year-old men and up to 40% of 70-year-old men.

3 weeks ago | bioworld.com | Coia Dulsat

CancerLoss of Y chromosome in cancer, immune cells: a new clue to cancer outcomesResearchers from the University of Arizona have unveiled that coordinated Y chromosome loss in both cancer cells and immune cells may explain the worse prognosis in people with this alteration. The loss of the Y chromosome (LOY) is one of the most frequent somatic mutations in men, particularly with advancing age.

3 weeks ago | bioworld.com | Coia Dulsat

CancerLoss of Y chromosome in cancer, immune cells: a new clue to cancer outcomesResearchers from the University of Arizona have unveiled that coordinated Y chromosome loss in both cancer cells and immune cells may explain the worse prognosis in people with this alteration. The loss of the Y chromosome is one of the most frequent somatic mutations in men, particularly with advancing age. BioWorld MedTech Cancer